CLINICAL_TRIALS
trial_result
· 2020-09-09
Clinical Trial Update: Treatment of Hemoglobin SC Disease With Hydroxyurea [Phase 2]
Summary
Phase 2 clinical trial evaluating hydroxyurea for Hemoglobin SC disease was terminated with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Hemoglobin SC Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-09-09